0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.190.232. Please contact the publisher to request reinstatement.

Journal Articles

in Diabetes Mellitus
 421-440 of 539 Articles
Original Contribution |  FREE
Gayle E. Reiber, MPH, PhD; Douglas G. Smith, MD; Carolyn Wallace, PhD; et al.
JAMA. 2002;287(19):2552-2558. doi:10.1001/jama.287.19.2552.

Original Contribution |  FREE
Andrew J. Karter, PhD; Assiamira Ferrara, MD, PhD; Jennifer Y. Liu, MPH; et al.
JAMA. 2002;287(19):2519-2527. doi:10.1001/jama.287.19.2519.

Original Contribution |  FREE
Tien Yin Wong, MD, MPH; Ronald Klein, MD, MPH; A. Richey Sharrett, MD, DrPH; et al.
JAMA. 2002;287(19):2528-2533. doi:10.1001/jama.287.19.2528.

Original Contribution |  FREE
Arleta Rewers, MD, PhD; H. Peter Chase, MD; Todd Mackenzie, PhD; et al.
JAMA. 2002;287(19):2511-2518. doi:10.1001/jama.287.19.2511.

Original Contribution |  FREE
Kim E. Innes, MSPH, PhD; Tim E. Byers, MD, MPH; Julie A. Marshall, PhD; et al.
JAMA. 2002;287(19):2534-2541. doi:10.1001/jama.287.19.2534.

Original Contribution |  FREE
The CDC Diabetes Cost-effectiveness Group
JAMA. 2002;287(19):2542-2551. doi:10.1001/jama.287.19.2542.

JAMA Patient Page |  FREE
JAMA. 2002;287(19):2608. doi:10.1001/jama.287.19.2608.

Review |  FREE
Joshua A. Beckman, MD, MS; Mark A. Creager, MD; Peter Libby, MD
JAMA. 2002;287(19):2570-2581. doi:10.1001/jama.287.19.2570.

Special Communication | 
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JAMA. 2002;287(19):2563-2569. doi:10.1001/jama.287.19.2563.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2002;287(19):2496-2497. doi:10.1001/jama.287.19.2496.

Medical News & Perspectives | 
Mike Mitka
JAMA. 2002;287(19):2488-2491. doi:10.1001/jama.287.19.2488-JMN0515-2-1.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2002;287(19):2497-2499. doi:10.1001/jama.287.19.2497-JWR0515-2-1.

Special Communication | 
David S. Ludwig, MD, PhD
JAMA. 2002;287(18):2414-2423. doi:10.1001/jama.287.18.2414.

Quick Uptakes | 
Mike Mitka
JAMA. 2002;287(16):2067. doi:10.1001/jama.287.16.2067-JQU20004-3-1.

Clinical Investigation |  FREE
Markus C. Stühlinger, MD; Fahim Abbasi, MD; James W. Chu, MD; et al.
JAMA. 2002;287(11):1420-1426. doi:10.1001/jama.287.11.1420.

Perspectives on Care at the Close of Life: CODA | 
Amy J. Markowitz, JD; Michael W. Rabow, MD
JAMA. 2002;287(7):882. doi:10.1001/jama.287.7.882.

Medical News & Perspectives | 
Brian Vastag
JAMA. 2002;287(6):701-702. doi:10.1001/jama.287.6.701.

The World in Medicine | 
Joan Stephenson, PhD
JAMA. 2002;287(6):706. doi:10.1001/jama.287.6.706-JWM20002-4-1.

Editorial | 
Wendy Levinson, MD, FRCPC; Catherine D. DeAngelis, MD, MPH
JAMA. 2002;287(3):379. doi:10.1001/jama.287.3.379.

Scientific Review and Clinical Applications |  FREE
Silvio E. Inzucchi, MD
JAMA. 2002;287(3):360-372. doi:10.1001/jama.287.3.360.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Case Report/Case Series  | 
Liraglutide-Induced Autoimmune Hepatitis
Emily Kern, MD; Lisa B. VanWagner, MD, MS; Guang-Yu Yang, MD, PhD; et al.
JAMA Ophthalmology
Original Investigation  | 
Eye Care Availability and Access Among Individuals With Diabetes, Diabetic Retinopathy, or Age-Related Macular Degeneration
Diane M. Gibson, PhD
JAMA Internal Medicine
Original Investigation  | 
Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus:  A Meta-analysis
Jun Cheng, MD; Wen Zhang, MMed; Xiaohui Zhang, MMed; et al.
JAMA Internal Medicine
Invited Commentary  | 
So Much Insulin, So Much Hypoglycemia
Sei J. Lee, MD, MAS